Literature DB >> 7241861

Cardiotoxic effects of 5-fluorouracil in the guinea pig.

I Matsubara, J Kamiya, S Imai.   

Abstract

In order to search into the underlying mechanisms of ECG changes suggestive of ischemia observed in humans and in rabbits after administration of 5-fluorouracil (5-FU), experiments were performed in anesthetized open-chest guinea pigs. The substance produced similar ECG changes in this species as well, after a rather long latent period of around 3 hours after intravenous administration. The incidence of ECG abnormality in animals given 60 mg/kg was 7/7, while that in animals given 30 mg/kg was 4/9. with 10-20 mg/kg, ECG changes were not observed during an experimental period as long as 5 hours. Associated with these ECG changes, a depletion of the high-energy phosphate compounds of the ventricular myocardium was observed. Analysis of tricarboxylic acid cycle (TCA cycle) intermediates revealed an accumulation of citrate within the myocardium, suggesting a malfunction of TCA cycle resulting from an inhibition of aconitase by fluorocitrate, as a cause of depletion of the high-energy phosphates. It is highly probable that the accumulation of citrate was due to the formation of fluoroacetate, an inhibitor of aconitase, from 5-FU via alpha-fluoro-beta-alanine, a major degradation product of 5-FU, for it is known that beta-alanine is usually converted to acetate.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7241861     DOI: 10.1254/jjp.30.871

Source DB:  PubMed          Journal:  Jpn J Pharmacol        ISSN: 0021-5198


  27 in total

Review 1.  The applications of the novel polymeric fluoropyrimidine F10 in cancer treatment: current evidence.

Authors:  William H Gmeiner; Waldemar Debinski; Carol Milligan; David Caudell; Timothy S Pardee
Journal:  Future Oncol       Date:  2016-06-09       Impact factor: 3.404

2.  Variant angina pectoris associated with FOLFOX4 therapy.

Authors:  Hiromichi Yamane; Minoru Matsubara; Shigeki Umemura; Toshimitsu Suwaki; Haruhito Kamei; Nagio Takigawa; Katsuyuki Kiura; Mitsune Tanimoto
Journal:  World J Gastrointest Oncol       Date:  2011-11-15

3.  5-fluorouracil induced pericarditis.

Authors:  Ammar Killu; Malini Madhavan; Kavita Prasad; Abhiram Prasad
Journal:  BMJ Case Rep       Date:  2011-04-15

4.  The clinical syndrome of 5-fluorouracil cardiotoxicity.

Authors:  J F Ensley; B Patel; R Kloner; J A Kish; J Wynne; M al-Sarraf
Journal:  Invest New Drugs       Date:  1989-04       Impact factor: 3.850

Review 5.  Cardiotoxicity of the antiproliferative compound fluorouracil.

Authors:  K Becker; J F Erckenbrecht; D Häussinger; T Frieling
Journal:  Drugs       Date:  1999-04       Impact factor: 9.546

6.  Acute myocardiotoxicity during 5-fluorouracil therapy.

Authors:  B Misset; B Escudier; B Leclercq; D Rivara; P Rougier; G Nitenberg
Journal:  Intensive Care Med       Date:  1990       Impact factor: 17.440

7.  Capecitabine-induced cardiotoxicity: case report and review of the literature.

Authors:  C Ang; M Kornbluth; M P Thirlwell; R D Rajan
Journal:  Curr Oncol       Date:  2010-02       Impact factor: 3.677

8.  Acute coronary syndrome associated with continuous 5-Fluorouracil infusion in a patient with metastatic colorectal cancer-a case report with a discussion on this clinical dilemma.

Authors:  Carlos Eduardo Paiva; Bianca Sakamoto Ribeiro Paiva; Rodrigo Garita; Odair Carlito Michelin; Katashi Okoshi
Journal:  J Gastrointest Cancer       Date:  2009

9.  Rapid Extracorporeal Membrane Oxygenation Overcomes Fulminant Myocarditis Induced by 5‑Fluorouracil.

Authors:  Alok R Amraotkar; Ajay Pachika; Kendra J Grubb; Andrew P DeFilippis
Journal:  Tex Heart Inst J       Date:  2016-04-01

10.  5-Fluorouracil-induced acute reversible heart failure not explained by coronary spasms, myocarditis or takotsubo: lessons from MRI.

Authors:  Yama Fakhri; Morten Dalsgaard; Dorte Nielsen; Per Lav Madsen
Journal:  BMJ Case Rep       Date:  2016-06-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.